ask="9.90"
ask_size="500"
average_daily_volume="264092"
bid="9.40"
bid_size="1000"
book_value="2.66"
change="+0.02"
change_from_200_day_moving_average="1.23"
change_from_50_day_moving_average="0.32"
change_from_52_week_high="-0.82"
change_From_52_week_low="3.25"
change_in_percent="+0.20%"
close="10.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="14471000"
high="10.30"
high_52_weeks="11.07"
last_trade_date="3/6/2017"
last_trade_price="10.25"
last_trade_size="13081"
last_trade_time="4:00pm"
low="9.99"
low_52_weeks="7.00"
market_capitalization="187.58M"
moving_average_200_day="9.02"
moving_average_50_day="9.93"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.11"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.68%"
percent_change_from_50_day_moving_average="+3.27%"
percent_change_from_52_week_high="-7.41%"
percent_change_from_52_week_low="+46.43%"
previous_close="10.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.85"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="8.67"
stock_exchange="NGM"
symbol="AKBA"
volume="445607"
weeks_range_52="7.00 - 11.07"
